- Check Our Services
Driving Change Through Research, Innovation, and Capacity Building
☆☆☆☆☆ Rated 5 out of 5
Amyloidosis Africa leads a portfolio of strategic, multi-country initiatives aimed at improving awareness, early diagnosis, and patient outcomes in cardiac amyloidosis across Africa.
A Strategic Approach to Addressing Cardiac Amyloidosis in Africa
Cardiac amyloidosis, particularly transthyretin amyloid cardiomyopathy (ATTR-CM), remains significantly underdiagnosed across Africa due to limited awareness, restricted access to diagnostic tools, and gaps in clinical data.
At Amyloidosis Africa, our work is structured around three core pillars: research and innovation, data generation, and capacity building. Through these pillars, we aim to strengthen healthcare systems, support clinicians, and improve patient pathways across diverse African settings.
Our projects are designed to be scalable, collaborative, and aligned with global efforts to improve recognition and management of cardiac amyloidosis.
Research & Innovation
Advancing the use of artificial intelligence and clinical research to improve early detection and diagnostic accuracy of cardiac amyloidosis. and American Heart Association .
Data & Evidence Generation
Generating continent-wide data through surveys and registries to inform policy, education, and clinical practice..
Awareness & Capacity Building
Strengthening clinician education and healthcare system readiness to improve recognition, diagnosis, and patient care.
Our Key Initiatives
A growing portfolio of projects addressing the most critical gaps in cardiac amyloidosis across Africa.
Pan-African Cardiac Amyloidosis Awareness & Practice Survey
A multi-country survey assessing awareness, diagnosis, and management of cardiac amyloidosis across Africa.
Amyloidosis Awareness and Capacity Building in Africa
Strengthening clinician awareness and diagnostic capacity for cardiac amyloidosis across African healthcare systems.
AI-ECG for Early Detection of Cardiac Amyloidosis in Africa
Leveraging AI and ECG data to improve early detection of cardiac amyloidosis in underserved African populations.
Our Impact
Through our projects, Amyloidosis Africa is working to transform the landscape of cardiac amyloidosis across the continent.
We aim to:
- Improve early detection and diagnosis
- Strengthen healthcare workforce capacity
- Generate high-quality, Africa-specific data
- Build sustainable collaborations with local and international partners
Our initiatives are designed not only to address current gaps but also to create long-term, scalable solutions that improve patient outcomes across diverse healthcare settings.
Collaborate With Us
Amyloidosis Africa actively seeks partnerships with academic institutions, healthcare organizations, industry leaders, and global health stakeholders.
We welcome collaboration in:
- Research and clinical studies
- Data generation and registries
- Education and training programs
- Technology and innovation (AI, diagnostics)
Together, we can accelerate progress in the recognition and management of cardiac amyloidosis in Africa.
Join Us in Transforming Cardiac Amyloidosis Care in Africa
Whether you are a clinician, researcher, organization, or potential partner, your collaboration can help drive meaningful change. Together, we can improve awareness, enable earlier diagnosis, and build stronger healthcare systems for patients affected by cardiac amyloidosis across Africa.
We advance cardiac amyloidosis care across Africa through collaboration, training, and research. Join us to change the future of heart health and empower local clinicians with knowledge and tools.
- Support cardiac care in Africa
- Give what you can to help
- Join our research network!
- Follow updates and news